首页> 外国专利> With benzyl substituted indazoles as inhibitors of BUB1, useful for the Treatment or prophylaxis of a disease hiperproliferativa and / or a Disorder that responds to the Induction of cell death, a process for the preparation of these Compounds, and compounds intermediari Os

With benzyl substituted indazoles as inhibitors of BUB1, useful for the Treatment or prophylaxis of a disease hiperproliferativa and / or a Disorder that responds to the Induction of cell death, a process for the preparation of these Compounds, and compounds intermediari Os

机译:使用苄基取代的吲唑类作为BUB1抑制剂,可用于治疗或预防可引起细胞死亡的hiperproliferativa和/或疾病,这些化合物的制备方法以及中间体Os

摘要

1.1.1.1.1.2.1.1.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.1.2.1.2.2.2.2.2.2.2.2.2.1.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.1.2.2.2.2.2.2.2.2.2.2.2 This document also introduces the preparation procedure of these compounds and the intermediate compounds used in the preparation process. The new compound has better pharmacological properties, especially enhances the inhibition of bbb1 target.1. When it is used in combination with other drugs, the greater power of limiting diffusion and / or reducing drug interaction; / P
机译:1.1.1.1.1.2.1.1.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.1.2.1.2.2.2.2.2.2.2.2.2.1.2.2.2.2.2.2.2.2。 2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.1.2.2.2.2.2.2.2.2.2.2.2本文件还介绍了这些化合物的制备方法以及用于准备过程。新化合物具有较好的药理特性,尤其是增强了对bbb1靶标的抑制作用。与其他药物联合使用时,具有更大的限制扩散和/或减少药物相互作用的能力; / P>

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号